Joentausta, R M
Kujala, P M
Visakorpi, T
Tammela, T L J
Murtola, T J
Article History
Received: 29 March 2016
Revised: 28 May 2016
Accepted: 25 June 2016
First Online: 9 August 2016
Competing interests
: TLJ Tammela is a paid consultant for Astellas, GSK, Pfizer, Orion Pharma and Amgen; TJ Murtola receives lecture fees from Janssen-Cilag and MSD and is a paid consultant for Astellas. The other authors declare no conflict of interest.